INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 134 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,992,000 | +11.1% | 76,281 | -20.8% | 0.51% | +0.4% |
| Q3 2021 | $3,592,000 | +8.6% | 96,358 | +18.9% | 0.51% | +15.1% |
| Q2 2021 | $3,308,000 | +5.4% | 81,031 | -12.4% | 0.44% | +3.0% |
| Q1 2021 | $3,139,000 | -26.8% | 92,504 | -31.4% | 0.43% | -30.5% |
| Q4 2020 | $4,290,000 | -27.4% | 134,891 | -41.4% | 0.62% | -32.6% |
| Q3 2020 | $5,907,000 | -14.8% | 230,203 | -14.8% | 0.92% | -18.4% |
| Q2 2020 | $6,937,000 | +158.5% | 270,219 | +54.8% | 1.13% | +130.8% |
| Q1 2020 | $2,684,000 | -23.2% | 174,594 | +71.4% | 0.49% | +3.4% |
| Q4 2019 | $3,496,000 | -55.1% | 101,889 | -83.0% | 0.47% | -57.3% |
| Q2 2019 | $7,791,000 | +80.9% | 600,236 | +69.8% | 1.11% | +89.6% |
| Q1 2019 | $4,307,000 | +15.6% | 353,592 | +8.1% | 0.59% | +4.1% |
| Q4 2018 | $3,727,000 | -16.0% | 327,226 | +60.0% | 0.56% | -5.7% |
| Q3 2018 | $4,437,000 | +40.6% | 204,470 | +14.5% | 0.60% | +33.6% |
| Q2 2018 | $3,156,000 | +41.2% | 178,590 | +68.2% | 0.45% | +45.1% |
| Q1 2018 | $2,235,000 | -17.5% | 106,182 | -43.3% | 0.31% | -8.9% |
| Q4 2017 | $2,709,000 | -7.1% | 187,120 | +1.2% | 0.34% | -5.1% |
| Q3 2017 | $2,917,000 | +50.2% | 184,836 | +18.2% | 0.36% | +49.0% |
| Q2 2017 | $1,942,000 | +16.8% | 156,349 | +52.8% | 0.24% | +17.7% |
| Q1 2017 | $1,663,000 | – | 102,326 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |